US 7528253
Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
granted A61PA61P11/00A61P11/06
Quick answer
US patent 7528253 (Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity) held by Theravance, Inc. expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P11/08, A61P43/00